Top Markets
Coin of the day
Theraclion SA Theraclion SA

Theraclion SA

ALTHE
Rank in Stocks #15409
Theraclion SA develops echotherapy solutions using high intensity focused... Theraclion SA develops echotherapy solutions using high intensity focused ultrasound system. It offers SONOVEIN, a robotic solution for non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment and protects the patient's skin and optimizes the image quality. The company was founded in 2004 and is based in Malakoff, France.
Share Price
$0.78404857
Market Cap
$36.98M
Change (1 day)
-1.49%
Change (1 year)
139.26%
Country
FR
Trade Theraclion SA (ALTHE)

Category

Earnings for Theraclion SA (ALTHE)
Earnings in Dec 2025 TTM: $-7.66M
According to Theraclion SA latest financial reports the company's current earnings are $-7.66M. In 2023 the company made an earning of $-5.22M, an increase over its 2022 earnings that were of $-6.40M. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Theraclion SA from 2010 to 2026
Earnings at the end of each year
Year Earnings Change
2026 (TTM) $-7.66M 9.18%
2024 $-7.01M 34.31%
2023 $-5.22M -18.39%
2022 $-6.40M 21.21%
2021 $-5.28M -6.31%
2020 $-5.64M -0.76%
2019 $-5.68M -32.53%
2018 $-8.42M -4.86%
2017 $-8.85M 8.51%
2016 $-8.15M 3.71%
2015 $-7.86M 25.89%
2014 $-6.24M 1.16%
2013 $-6.17M 27.33%
2012 $-4.85M 79.96%
2011 $-2.69M -12.86%
2010 $-3.09M 0.00%
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
$8.14B -106,355.98%
US
$4.60B -60,168.52%
US
$6.14B -80,241.52%
IE
$3.74B -48,964.43%
US
$1.30B -17,049.77%
US